Blocking platelets more: are we skating on thin ice?

Heart. 1998 Jan;79(1):5-6. doi: 10.1136/hrt.79.1.5.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Abciximab
  • Antibodies, Monoclonal / therapeutic use
  • Aspirin / therapeutic use
  • Cerebrovascular Disorders / prevention & control*
  • Clopidogrel
  • Humans
  • Immunoglobulin Fab Fragments / therapeutic use
  • Myocardial Infarction / prevention & control
  • Platelet Aggregation Inhibitors / adverse effects
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Platelet Glycoprotein GPIIb-IIIa Complex / antagonists & inhibitors
  • Ticlopidine / analogs & derivatives
  • Ticlopidine / therapeutic use

Substances

  • Antibodies, Monoclonal
  • Immunoglobulin Fab Fragments
  • Platelet Aggregation Inhibitors
  • Platelet Glycoprotein GPIIb-IIIa Complex
  • Clopidogrel
  • Ticlopidine
  • Aspirin
  • Abciximab